Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Brain Communications, 2023

Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosis

Zhu W., Chen C., Zhang L. et al.

Communications Biology, 2023

Identification of circulating proteins associated with general cognitive function among middle-aged and older adults

Tin A., Fohner A., Yang Q. et al.

BMC Medicine, 2023

Associations of ultra-processed food consumption, circulating protein biomarkers, and risk of cardiovascular disease

Li H., Wang Y., Sonestedt E. et al.

Kidney International Reports, 2023

Proteome-Wide Changes in Blood Biomarkers During Hemodialysis

Lanktree M., Collister D., Pigyere M. et al.

Kidney Medicine, 2023

Protein Biomarkers and Major Cardiovascular Events in Older People With Advanced CKD: The European Quality (EQUAL) Study

Hayward S., Chesnaye N., Hole B. et al.

Cell Reports Medicine, 2023

Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese

Jia X., Song E., Liu Y. et al.

Clinical and Translational Allergy, 2023

Inflammatory related plasma proteins involved in acute preschool wheeze

Holmdahl I., Chakraborty S., Hoyer A. et al.

Clinical Immunology, 2023

In-depth immune profiling reveals advanced B- and T-cell differentiation to be associated with Th1-driven immune dysregulation in common variable immunodeficiency

Hultberg J., Blixt E., Göransson R. et al.

Molecular Psychiatry, 2023

Mitochondrial hypermetabolism precedes impaired autophagy and synaptic disorganization in App knock-in Alzheimer mouse models

Naia L., Shimozawa M., Bereczki E. et al.

Biomedicine & Pharmacotherapy, 2023

Decoding clinical and molecular pathways of liver dysfunction in Psoriatic Arthritis: Impact of cumulative methotrexate doses

Ruiz-Ponce M., Cuesta-López L., López-Montilla M. et al.

Nature Communications, 2023

Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis

Åkesson J., Hojjati S., Hellberg S. et al.

Journal of the American Heart Association, 2023

Proteomics and Precise Exercise Phenotypes in Heart Failure With Preserved Ejection Fraction: A Pilot Study

Shah R., Hwang S., Murthy V. et al.

Annals of Nutrition and Metabolism, 2023

Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial

Stenlid R., Cerenius S., Manell H. et al.

Nature Genetics, 2023

Rare variants with large effects provide functional insights into the pathology of migraine subtypes, with and without aura

Bjornsdottir G., Chalmer M., Stefansdottir L. et al.

Journal of Neurology, Neurosurgery & Psychiatry, 2023

Proximity extension assay-based discovery of biomarkers for disease activity in chronic inflammatory demyelinating polyneuropathy

Wieske L., Michael M., in 't Veld S. et al.

Journal of Investigative Dermatology, 2023

Alterations to the Hidradenitis Suppurativa Serum Proteome with Spleen Tyrosine Kinase Antagonism: Proteomic Results from a Phase 2 Clinical Trial

Flora A., Jepsen R., Pham J. et al.

Journal of Clinical Medicine, 2023

Cerebrospinal Fluid Proteomic Changes after Nusinersen in Patients with Spinal Muscular Atrophy

Beaudin M., Kamali T., Tang W. et al.

Biomedicine & Pharmacotherapy, 2023

Angiotensin-converting enzyme inhibitors and statins therapies-induced changes in omics profiles in humans and transgenic tau mice

Collu R., Giunti E., Daley S. et al.

Translational Psychiatry, 2023

Multivariate analyses of immune markers reveal increases in plasma EN-RAGE in first-episode psychosis patients

Korhonen L., Paul E., Wåhlén K. et al.

Critical Care Explorations, 2023

Validating a Proteomic Signature of Severe COVID-19

Cosgriff C., Miano T., Mathew D. et al.

4586 publications